Strengthening European Health Systems
Investing in Healthcare Innovation
Healthcare systems across Europe are facing unprecedented challenges from an ageing population and a rising tide of chronic diseases that are driving ever-increasing demand for services. While we need to keep investing in our health systems, many opportunities exist to make healthcare more efficient, improving long-term outcomes within existing budgets and creating fiscal space for the uptake of high-impact medicines and other medical innovations that can transform lives.
This Financial Times webinar, held in partnership with EFPIA brought together policy makers and other stakeholders from across the healthcare and life sciences continuum to discuss how taking a holistic approach to healthcare spending and outcomes, and using the right policy to address the right issue can drive innovation while keeping health systems sustainable and resilient for the longer term.
Financing Healthcare
What are the main challenges that need to be addressed to spend ‘smarter’ on investments that deliver long-term outcomes and healthier populations and move away from a siloed, short-term approach to healthcare organisation and financing?
Innovation
What are the examples of innovations and best practice that have created efficiencies and yielded improved outcomes for patients, society, and healthcare systems?
Investments
In times of geopolitical, energy, cost-of-living crises, and high inflation, how can smart investments strengthen the resilience and sustainability of our health systems while meeting increasing demand for healthcare?
"I found the content interesting, valuable, and cutting-edge. It helped me feel like I was staying on top of novel issues in the area of oncology."
Testimonial from 'Rethinking the Future of Cancer Care', our previous event in partnership with EFPIA
Biopharma Manufacturing for Advanced Therapies
22 March 2023
The Role of Big Pharma in Consumer Healthcare
19 April 2023
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice